These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34744006)

  • 21. Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8(+) T cell epitopes.
    Liu SD; Su J; Zhang SM; Dong HP; Wang H; Luo W; Wen Q; He JC; Yang XF; Ma L
    J Cell Mol Med; 2016 Sep; 20(9):1718-28. PubMed ID: 27072810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development.
    Ong E; He Y; Yang Z
    Infect Genet Evol; 2020 Jun; 80():104186. PubMed ID: 31923726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational approaches in epitope design using DNA binding proteins as vaccine candidate in Mycobacterium tuberculosis.
    Sunita ; Singhvi N; Singh Y; Shukla P
    Infect Genet Evol; 2020 Sep; 83():104357. PubMed ID: 32438080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis.
    Mustafa AS; Shaban FA
    Tuberculosis (Edinb); 2006 Mar; 86(2):115-24. PubMed ID: 16039905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
    Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
    Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
    McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
    Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational Identification and Characterization of a Promiscuous T-Cell Epitope on the Extracellular Protein 85B of
    Hossain MS; Azad AK; Chowdhury PA; Wakayama M
    Biomed Res Int; 2017; 2017():4826030. PubMed ID: 28401156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico identification of potential antigenic proteins and promiscuous CTL epitopes in Mycobacterium tuberculosis.
    Sundaramurthi JC; Brindha S; Shobitha SR; Swathi A; Ramanandan P; Hanna LE
    Infect Genet Evol; 2012 Aug; 12(6):1312-8. PubMed ID: 22484107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in
    Ramaiah A; Nayak S; Rakshit S; Manson AL; Abeel T; Shanmugam S; Sahoo PN; John AJUK; Sundaramurthi JC; Narayanan S; D'Souza G; von Hoegen P; Ottenhoff THM; Swaminathan S; Earl AM; Vyakarnam A
    Front Immunol; 2019; 10():195. PubMed ID: 30814998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE_PGRS 33 protein of Mycobacterium tuberculosis.
    Chaitra MG; Shaila MS; Nayak R
    J Med Microbiol; 2007 Apr; 56(Pt 4):466-474. PubMed ID: 17374885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential.
    Chaitra MG; Hariharaputran S; Chandra NR; Shaila MS; Nayak R
    Vaccine; 2005 Jan; 23(10):1265-72. PubMed ID: 15652669
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection.
    Ates LS; Sayes F; Frigui W; Ummels R; Damen MPM; Bottai D; Behr MA; van Heijst JWJ; Bitter W; Majlessi L; Brosch R
    PLoS Pathog; 2018 Jun; 14(6):e1007139. PubMed ID: 29912964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance.
    Mustafa AS
    Tuberculosis (Edinb); 2005; 85(5-6):367-76. PubMed ID: 16253561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence.
    Heijmenberg I; Husain A; Sathkumara HD; Muruganandah V; Seifert J; Miranda-Hernandez S; Kashyap RS; Field MA; Krishnamoorthy G; Kupz A
    Vaccine; 2021 Dec; 39(50):7265-7276. PubMed ID: 34420788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
    Kashyap M; Jaiswal V; Farooq U
    Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of T-cell immunogenicity of two PE/PPE proteins of Mycobacterium tuberculosis.
    Chaitra MG; Shaila MS; Nayak R
    J Med Microbiol; 2008 Sep; 57(Pt 9):1079-1086. PubMed ID: 18719176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology.
    Bibi S; Ullah I; Zhu B; Adnan M; Liaqat R; Kong WB; Niu S
    Sci Rep; 2021 Jan; 11(1):1249. PubMed ID: 33441913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.